(Q44432093)

2 December 2017

title

Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway (English)

1 reference

2 December 2017

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1093/JNCI/95.9.652

31 December 2023

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

nerve tissue protein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

31 December 2023

David T Curiel

1 reference

2 December 2017

Juan Fueyo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

Candelaria Gomez-Manzano

object named as

Candelaria Gomez-Manzano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

Ramon Alemany

1 reference

2 December 2017

Asadullah Khan

1 reference

2 December 2017

Ta-Jen Liu

1 reference

2 December 2017

Hong Jiang

1 reference

2 December 2017

Kaori Suzuki

1 reference

2 December 2017

Raymond Sawaya

1 reference

2 December 2017

Gregory N. Fuller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

Charles A. Conrad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

Michael G. Lemoine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

W. K Alfred Yung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

Frederick F. Lang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734316

31 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

7 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12734316

Journal of the National Cancer Institute

31 December 2023

published in

1 reference

2 December 2017

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

652-660

1 reference

Malignant glioma: genetics and biology of a grave matter.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

The INK4a/ARF network in tumour suppression

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Cellular targets for transformation by the adenovirus E1A proteins

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Targeted adenoviral vectors

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Biotechnology (Reading, Mass.)

31 December 2023

265

1995

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Alpha v integrins as receptors for tumor targeting by circulating ligands.

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Suppression of human glioma growth by adenovirus-mediated Rb gene transfer

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Characterization of p53 and p21 Functional Interactions in Glioma Cells en Route to Apoptosis

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

An implantable guide-screw system for brain tumor studies in small animals.

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Xylene-free method for histological preparation: a multicentre evaluation

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Nonparametric Estimation from Incomplete Observations

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Replicative adenoviruses for cancer therapy

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization.

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Blood clearance rates of adenovirus type 5 in mice

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies.

31 December 2023

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.652

31 December 2023

Identifiers

DOI

1 reference

2 December 2017

1 reference